LYMPHOBLASTIC LEUKEMIA
Clinical trials for LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for babies with leukemia: immunotherapy combo tested
Disease control Recruiting nowThis study tests a new treatment plan for infants (up to 1 year old) with a type of leukemia. It adds an immunotherapy drug called blinatumomab to standard chemotherapy to try to wipe out any leftover cancer cells. The goal is to see if this combination is safe and works better t…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for relapsed t-cell blood cancers: experimental drug combo enters trial
Disease control Recruiting nowThis study tests a new experimental drug, LP-118, combined with three other medicines (ponatinib, vincristine, and dexamethasone) in adults with T-cell acute lymphoblastic leukemia or lymphoma that has come back or not responded to treatment. The goal is to find a safe dose and s…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo therapy aims to rebuild strength in young cancer survivors after transplant
Disease control Recruiting nowThis study tests whether a tailored exercise program combined with a vitamin-like supplement (NAD+ precursor) can improve muscle mass, strength, and fitness in teens and young adults who had a bone marrow transplant for leukemia or other blood disorders. Participants will be rand…
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 22, 2026 13:50 UTC